Inventor · disambiguated record
Takuya Osada
Also filed as: OSADA TAKUYA
11 granted patents·9 pending applications·20 citations·filing 2007–2023
85Inventor score
Top patents by PatentIndex Score
20 records- 0187US11207409B2X-RAY psoralen activated cancer therapy (X-PACT) with associated treatmentsIMMUNOLIGHT LLC·Filed 2018·Granted Dec 28, 2021·3 cites·32 claims
- 0284US10487143B2Vaccines against HER3 antigens and methods of using the sameUNIV DUKE·Filed 2017·Granted Nov 26, 2019·3 cites·19 claims
- 0382US9956276B2Vaccines against antigens involved in therapy resistance and methods of using sameUNIV DUKE·Filed 2013·Granted May 1, 2018·8 cites·16 claims
- 0481US11305131B2X-ray psoralen activated cancer therapy (X-PACT)IMMUNOLIGHT LLC·Filed 2019·Granted Apr 19, 2022·1 cites·37 claims
- 0581US10842857B2Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the sameUNIV DUKE·Filed 2018·Granted Nov 24, 2020·1 cites·16 claims
- 0678US11235043B2Vaccines against antigens involved in therapy resistance and methods of using sameUNIV DUKE·Filed 2018·Granted Feb 1, 2022·1 cites·17 claims
- 0774US10441810B2X-ray psoralen activated cancer therapy (X-PACT)IMMUNOLIGHT LLC·Filed 2017·Granted Oct 15, 2019·3 cites·41 claims
- 0871US12083172B2Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the sameUNIV DUKE·Filed 2020·Granted Sep 10, 2024·0 cites·12 claims
- 0968US10842855B2Vaccines against an oncogenic isoform of ESR1 and methods of using the sameUNIV DUKE·Filed 2018·Granted Nov 24, 2020·0 cites·16 claims
- 1067US11992697B2X-ray psoralen activated cancer therapy (X-PACT)IMMUNOLIGHT LLC·Filed 2022·Granted May 28, 2024·0 cites·35 claims
- 1164US2021069309A1Vaccines against an oncogenic isoform of esr1 and methods of using the sameUNIV DUKE·Filed 2020·Application pending·0 cites
- 1259US2025205467A1Systems and methods for the treatment of cancer using ultrasoundUNIV DUKE·Filed 2023·Application pending·0 cites
- 1353US2007297983A1Inhibition of breast carcinoma stem cell growth and metastasisFERRONE SOLDANO·Filed 2007·Application pending·0 cites
- 1451US2017196953A1VACCINES AGAINST AN ONCOGENIC ISOFORM OF HER2 (ErbB2) AND METHODS OF USING THE SAMEUNIV DUKE·Filed 2015·Application pending·0 cites
- 1551US2021330773A1Vaccines against antigens involved in therapy resistance and methods of using sameUNIV DUKE·Filed 2021·Application pending·0 cites
- 1646US11253580B2Cancer vaccines and methods of deliveryUNIV DUKE·Filed 2017·Granted Feb 22, 2022·0 cites·7 claims
- 1745US2017196952A1Vaccines against an oncogenic isoform of esr1 and methods of using the sameUNIV DUKE·Filed 2015·Application pending·0 cites
- 1844US2018282736A1Her3 vaccine vector compositions and methods of using the sameUNIV DUKE·Filed 2018·Application pending·0 cites
- 1939US2013005802A1Treatment of wnt/frizzled-related diseasesCHEN WEI·Filed 2010·Application pending·0 cites
- 2031US2017015758A1Compositions And Methods For Modulating And Redirecting Immune ResponsesMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Takuya Osada files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →